FDA Inspection
Osteotech, Inc.Osteotech, Inc. – FDA Inspection, Aug 12, 2021
Record Details
This FDA Inspection record concerns Osteotech, Inc., with an inspection on August 12, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Osteotech, Inc.
- Inspection Date
- August 12, 2021
- Product Type
- Biologics
View Company Profile
ID · 5d361e25-cf2a-4c5e-8652-100402b95bc5
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1150237
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Osteotech, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| June 18, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 30, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 10, 2017 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| May 6, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 16, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Osteotech, Inc.
- FDA Inspection 1245789 - 2024-06-18
- FDA Inspection 1060874 - 2018-07-30
- FDA Inspection 1021037 - 2017-08-10
- FDA Inspection 925160 - 2015-05-06
- FDA Inspection 845708 - 2013-08-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.